Bachir Latli

Title: Bachir Latli: Innovator in Neuronal Modulation

Introduction

Bachir Latli is a notable inventor based in Danbury, CT (US). He has made significant contributions to the field of pharmacology, particularly in the modulation of neuronal nicotinic acetylcholine receptors. His work focuses on developing novel compounds that can potentially treat various neurological and inflammatory conditions.

Latest Patents

Bachir Latli holds a patent for "Substituted pyridines as modulators of the mammalian neuronal nicotinic acetylcholine receptor." This patent includes 1 patent that describes compounds designed to modulate the neuronal nicotinic acetylcholine receptor (nAChR), specifically the mammalian nAChR (m-nAChR). The compounds are substituted pyridine derivatives, which include analogs of 1-[(6-chloro-3-pyridinyl)methyl]-2-imidazolidine and 1-[(6-chloro-3-pyridinyl)methyl]-2-iminothiazole. These compounds are intended for use as therapeutic agents to treat conditions such as Alzheimer's disease, inflammation, and pain management.

Career Highlights

Bachir Latli has established himself as a prominent figure in his field through his innovative research and development efforts. He is affiliated with the University of California, where he continues to explore the therapeutic potential of his inventions. His work has implications for treating a range of disorders, including CNS disorders and conditions related to smooth muscle contractions.

Collaborations

Bachir Latli collaborates with John E Casida, a fellow researcher, to further advance their understanding of neuronal modulation and its applications in medicine.

Conclusion

Bachir Latli's contributions to the field of pharmacology through his innovative patents highlight the potential for new treatments for various neurological and inflammatory conditions. His work exemplifies the importance of research and collaboration in advancing medical science.